Zomedica Corp. [ZOM] fell -23.49% so far this year. What now?

Zomedica Corp. [AMEX: ZOM] closed the trading session at $0.23 on 11/08/22. The day’s price range saw the stock hit a low of $0.23, while the highest price level was $0.24. The company report on October 18, 2022 that Zomedica to Present at LD Micro Main Event XV Conference.

China Can't Stop US$0.25 Stock from Mining Ultra-Rare Metal

Here's one little-known company — trading undiscovered below 25-cents per share — that's advancing one of the largest and highest quality REE deposits in all of North America... and the Chinese can't do a damn thing about it! It's early stage... and that's excellent news for individual investors like you who have the foresight to act decisively on an emerging megatrend that's already being measured in the Tens of $Billions.

Simply click here and the name & trading symbol are yours.


Zomedica Corp. (the “Company”) (NYSE American:ZOM) announced today that Larry Heaton, Zomedica’s Chief Executive Officer, is scheduled to provide a company overview and its prospects for growth at the LD Micro Main Event XV Conference on October 25, 2022 at the Luxe Sunset Boulevard Hotelin Bel Air, California.

To access the live webcast for the presentation on October 25th at 10am PDT/1:00 pm EDT, please visit https://me22.mysequire.com/ to access the Track 2 presentation; or check Zomedica’s website after the conference at https://investors.zomedica.com/events-presentations for an archived copy.

The stocks have a year to date performance of -23.49 percent and weekly performance of -6.27 percent. The stock has been moved at 12.42 percent over the last six months. The stock has performed 16.96 percent around the most recent 30 days and changed -39.09 percent over the most recent 3-months.

If compared to the average trading volume of 10.36M shares, ZOM reached to a volume of 7156506 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Zomedica Corp. [ZOM]:

The Average True Range (ATR) for Zomedica Corp. is set at 0.01, with the Price to Sales ratio for ZOM stock in the period of the last 12 months amounting to 17.46. The Price to Book ratio for the last quarter was 0.87, with the Price to Cash per share for the same quarter was set at 0.21.

ZOM stock trade performance evaluation

Zomedica Corp. [ZOM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.27. With this latest performance, ZOM shares gained by 16.96% in over the last four-week period, additionally plugging by 12.42% over the last 6 months – not to mention a drop of -59.36% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ZOM stock in for the last two-week period is set at 56.18, with the RSI for the last a single of trading hit 59.04, and the three-weeks RSI is set at 52.99 for Zomedica Corp. [ZOM]. The present Moving Average for the last 50 days of trading for this stock 0.2224, while it was recorded at 0.2302 for the last single week of trading, and 0.2694 for the last 200 days.

Zomedica Corp. [ZOM]: An insightful look at the core fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Zomedica Corp. [ZOM] shares currently have an operating margin of -517.14 and a Gross Margin at +46.32. Zomedica Corp.’s Net Margin is presently recorded at -444.78.

Return on Equity for this stock declined to -11.01, with Return on Assets sitting at -10.61.

Zomedica Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 42.40 and a Current Ratio set at 43.50.

Zomedica Corp. [ZOM]: Insider Ownership positions

There are presently around $22 million, or 9.90% of ZOM stock, in the hands of institutional investors. The top three institutional holders of ZOM stocks are: VANGUARD GROUP INC with ownership of 44,076,354, which is approximately 8.543% of the company’s market cap and around 1.48% of the total institutional ownership; BLACKROCK INC., holding 11,353,498 shares of the stock with an approximate value of $2.66 million in ZOM stocks shares; and CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC., currently with $2.62 million in ZOM stock with ownership of nearly 0.179% of the company’s market capitalization.

Positions in Zomedica Corp. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 30 institutional holders increased their position in Zomedica Corp. [AMEX:ZOM] by around 9,407,371 shares. Additionally, 43 investors decreased positions by around 26,827,151 shares, while 40 investors held positions by with 58,663,632 shares. The mentioned changes placed institutional holdings at 94,898,154 shares, according to the latest SEC report filing. ZOM stock had 9 new institutional investments in for a total of 3,334,542 shares, while 21 institutional investors sold positions of 5,404,232 shares during the same period.


Please enter your comment!
Please enter your name here